Delivery Order SPE2DB22D9304-SPE2DB24FSSL2
Award Date 1/12/24
Potential Completion Date 2/5/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $5,711.28, has a completion date of May 30, 2024 and was awarded on May 8, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The order has a potential value of $2,487.22 and a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to support military treatment facilities worldwide under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 133 mg/10 ml vials of the pharmaceutical product EXPAREL with a potential value of $4,283.46. The order has a completion date of February 7, 2024 and was awarded on January 17, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply pharmaceuticals...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of EXPAREL 133 MG/10 ML VIAL 10ML. This $1,427.82 contract award is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle under the DLA's SPE2DB program, which enables the agency to fulfill recurring pharmaceutical supply needs of military health facilities worldwide. DMS Pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563452317 EXPAREL 133 MG/10 ML VIAL 10ML. The order has a completion date of February 9, 2024 and a potential value of $3,437.04. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with the Defense Logistics Agency to supply a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide EXPAREL 133MG/10ML pharmaceutical products. The $2,855.64 contract was awarded on March 22, 2024 and has an ultimate completion date of April 8, 2024. This order is placed against DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with DLA under the SPE2DB program, which has a ceiling value of up to $4,999,999...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563426247 - EXPAREL 266 MG/20 ML VIAL 20ML. This order, valued at $4,974.44, was placed against an existing indefinite delivery contract with DMS Pharmaceutical Group to supply pharmaceuticals and medical products in support of military treatment facilities worldwide. The contract has no set-aside designation and is expected to be completed by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of EXPAREL 1.3% 20ML 10S. The contract, valued at $14,923.32, has a completion date of May 16, 2024 and is not set aside. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a wide range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,197,604 milliliters of the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML. The delivery order, which has a potential value of $18,924.36, will be fulfilled by January 18, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that supplies a variety of pharmaceutical and medical products to the federal government,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to deliver EXPAREL 266 MG/20 ML VIAL 20ML. The firm fixed-price contract has a potential value of $29,846.64 and a completion date of March 7, 2024. This delivery order is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, which enables DLA to issue orders for a wide range...